creatine and glp-1 & Support: An Unexpected Ally for Metabolic Health Optimize Your Weight Loss Journey

MariTide (AMG 133 / maridebart cafraglutide) is Amgens investigational, first-in-class bispecific molecule that combines GLP-1 receptor agonism with GIP-receptor antagonism using a peptide-antibody conjugate

You may have noticed people in your life have started shrinking too

There is no MHRA-approved indication for GLP-1 receptor agonists in Hashimoto's thyroiditis, and any such use would be off-label

GLP-1 agonists, including the medication we compound ourselves, have shown promising results for weight loss in clinical trials

( PMID: 35344001

Medication expectations sometimes differ from outcomes due to personalized language used before clinician review